CXCR4 and lung carcinoma: Chittasupho and colleagues demonstrated that conjugating the CXCR4-targeting peptide LFC131 onto PLGA NPs significantly enhanced the delivery of doxorubicin to CXCR4-expressing A549 lung cancer cells.